SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Griesshammer M, Heinze B, Hellman A, et al. Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients. Ann Hematol 1996;73:225230.
  • 2
    Weh HJ, Seeger D, Junge I, Hossfeld DK. Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia. Ann Hematol 1996;72:8182.
  • 3
    Mikhailova N, Sessarego M, Fugazza C, et al. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 1996;81:418422.
  • 4
    Scaravaglio P, Guglielmelli T, Giuliano E, et al. Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. Cancer Genet Cytogenet 2002;133:98101.
  • 5
    Gordon-Smith EC, Marsh JC, Gibson FM. Views on the pathophysiology of aplastic anemia. Int J Hematol 2002;76(Suppl 2):263266.
  • 6
    Massaro P, Foa P, Pomati M, et al. Polycythemia vera treated with recombinant interferon-alpha 2a: evidence of a selective effect on the malignant clone. Am J Hematol 1997;56:126128.
  • 7
    Petrini M, Simi P, Saglio G. Cytogenetic remission induced by interferon-alpha in a myeloproliferative disorder with trisomy 8. Br J Haematol 1996;92:941943.
  • 8
    Naifeld V, Montella L, Scalise A, Fruchtman S. Exploring polycythemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. Br J Haematol 2002;558566.
  • 9
    Feldman, Naifeld V, Schuster M, Roboz G, Chadburn A, Silver RT. The emergence of Ph, trisomy 8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate. Exp Hematol 2003;31:702707.
  • 10
    Medina J, Kantarjian H, Talpaz M, et al. Chromosome abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Cancer 2003;98:19051911.